Omnipod Horizon Pivotal Study (H-46880)
Study Goal(s): This study is a single-arm, multi-center, prospective clinical study to evaluate the effectiveness of the Omnipod Horizon Automated Glucose Control System in children aged 6-13.9 years and adults aged 14-70 years.
Eligibility Criteria: None
Investigators: Daniel DeSalvo, M.D. (site principal investigator), Siripoom McKay, M.D. (co-investigator)
Supported by: Insulet